European dietary supplements won’t cure what ails Procter & Gamble. The consumer products maker should focus on fixing its core business to resume growth.
WSJ.com: Heard on the Street, Wall Street Journal: Markets: Heard on the Street
Thu, 04/19/2018 - 2:57pm
European dietary supplements won’t cure what ails Procter & Gamble. The consumer products maker should focus on fixing its core business to resume growth.